| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.205 | 18.616 | 3.564 | 16.071 | 17.346 | 35.229 | 46.945 |
| Total Income - EUR | - | - | - | 2.205 | 18.616 | 3.564 | 16.071 | 17.346 | 35.229 | 46.946 |
| Total Expenses - EUR | - | - | - | 1.269 | 12.787 | 2.416 | 5.688 | 10.151 | 19.717 | 17.281 |
| Gross Profit/Loss - EUR | - | - | - | 936 | 5.828 | 1.148 | 10.383 | 7.195 | 15.512 | 29.665 |
| Net Profit/Loss - EUR | - | - | - | 870 | 5.270 | 1.064 | 9.951 | 6.885 | 15.167 | 28.284 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Anestplus Atimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 979 | 7.881 | 7.281 | 17.446 | 10.213 | 16.321 | 31.535 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 333 | 2.255 | 608 | 392 | 393 | 13.151 | 25.295 |
| Cash | - | - | - | 646 | 5.626 | 6.673 | 17.054 | 9.820 | 3.170 | 6.240 |
| Shareholders Funds | - | - | - | 913 | 6.165 | 7.111 | 16.905 | 6.933 | 15.216 | 28.333 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 66 | 1.716 | 170 | 542 | 3.280 | 1.105 | 3.202 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Anestplus Atimed S.r.l.